Greg Boyle
Oradell, NJ (USA)
Role(s):
Founder/Owner/Principal
OdorSCIENCE
Find More Startups
Startup
Location:
Columbus
Industry:
Bio-Technology
Year Founded:
2001
Number Employees:
1-10 people
Description:
NON CONFIDENTIAL SUMMARY PROPOSAL
Who:
1. OdorSCIENCE; Greg Boyle, Mindy Boyle. OdorSCIENCE has been offered to purchase [NAME of COMPANY] by the majority stockholder. OdorSCIENCE currently holds the North American distribution, sales and marketing rights for [Trademark Name] for ten years. [Trademark Name]™ is the absolute best technology for removing odors by releasing dmClO2 in measured amounts in any enclosed space. [NAME of COMPANY] developed and patented the release system for them most powerful antimicrobial available, chlorine dioxide. Safe for humans, animals and the environment, chlorine dioxide (ClO2) is a virucide, bactericide, fungicide and sporacide. Current markets include; auto, marine, sportsman, footwear, room decontamination, and many other uses. In addition to already profitably penetrating the odor elimination markets, [NAME of COMPANY] products purify any water anywhere, can be used for the health care industry in surface and air sanitizing, cold sterilization and even to destroy the MRSA superbug bacteria.
What:
1. To raise $500,000 in funding to purchase Avantec Technologies, Inc. ([NAME OF COMPANY]) assets that includes all [NAME OF COMPANY] patents, intellectual property, proprietary information and regulatory approvals. Along with current profits OS would complete an automated manufacturing process to meet demand, stabilize product quality, implement a global marketing, sales, pricing, and operational strategy which will grow sales, profits and stockholder value. [NAME OF COMPANY] holds the patents, intellectual property, EPA & FDA regulatory approvals, proprietary information and equipment for the manufacturing of dry media chlorine dioxide. (dmClo2) Chlorine Dioxide is considered the best broad spectrum biocide to safely destroy bacteria, virus, fungi and chemical compounds for sanitizing, disinfection and sterilization any surface and air. [NAME OF COMPANY] produces pouches to deliver ClO2 in aqueous solutions and in gaseous forms to destroy pathogens and odor. Simple humidity activated Micro Reactor (pouch) is easy and safe to use and provides results never seen before or never available before to industry or the consumer.
2. Current EPA approved products are used for water cooling treatment systems and hard surface disinfection, sterilization and the highest level odor control in any enclosed space. Possible and currently developed products now available for EPA approval, with proper funding are water purification, active fungicide, bactericide, and viruscide on any surface and in the air.
3. Market penetration would include commercial and retail consumer.
Where:
1. Current corporate office, laboratories and manufacturing in Columbus, OH, Paramus, NJ and Upstate, NY
When:
1. $100,000 ASAP and the close in approximately 45 days to close.
Why:
1. [NAME OF COMPANY] cannot keep up with sales growth in manufacturing, product quality product development and market and sales penetration for [Trademark Name], [Trademark Name], and Trademark Name].
2. Satisfy proven market demand in the categories of hard surface sanitizing, disinfection, sterilization and odor control in the air and on any surface in all identified categories.
3. Buy out current majority stock holder which includes; a) Satisfy outstanding debts; $300,000 callable note, $70,000 long-term convertible note, $40,000 current trade payables, $100,000 for transfer of public TSX stock to BBL, LLC. Balance for working capital. Combined with current sales and investment infusion would balance company to quickly realize value through profit and stock increase.
4. Purchase materials in volume to reduce cost to offer best quality and best price finished goods.
Investor Benefits & Exit Strategy
1. Realize immediate profits for current sales.
2. Profits, [NAME OF COMPANY] Stock, Board Position(s) Share in parent company of BBL, LLC.
3. Exit Strategy to be negotiated with investor. Remain private or consider IPO.
Call or Contact:
Greg Boyle, Cell [send me a message] – Office [send me a message] or (URL removed)